Circulating tumor DNA alterations in patients with metastatic castration‐resistant prostate cancer

Overview of attention for article published in Cancer (0008543X), January 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 7 news outlets
twitter: 30 X users

patent: 2 patents

Readers on

mendeley: 77 Mendeley

So far, Altmetric has seen 31 X posts from 30 X users, with an upper bound of 229,127 followers.

RT @GuardantAMEA: September marks Prostate Cancer Awareness Month. Check out this publication (https://t.co/RRkxa60jWW) to find out more ab…

September marks Prostate Cancer Awareness Month. Check out this publication (https://t.co/RRkxa60jWW) to find out more about how the Guardant360® liquid biopsy test can help to guide treatment decisions for patients with advanced stage prostate cancer. ht…

RT @neerajaiims: Many actionable targets are detected by ctDNA CGP in castration resistant prostate ca, important results given difficult t…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 27 additional X posts.